Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Disparity of Hawthorn Effects to Triglyceride/High-density Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics

NCT03663465 is registered in ClinicalTrials.gov with Calo Psychiatric Center as lead sponsor.

NCT NCT03663465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03663465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Disparity of Hawthorn Effects to Triglyceride/High-density Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics
Lead sponsor
Calo Psychiatric Center
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2013
Completion date
July 31, 2014
Enrollment
135 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia